Zanubrutinib
Polatuzumab Vedotin-piiq
Ibrutinib Plus Bendamustine and Rituximab
National Cancer Institute: Lymphoma—Patient Version
JNCCN: How to Manage Cancer Care During COVID-19 Pandemic
COVID-19 and Aggressive Lymphoma: Frequently Asked Questions Answered by ASH
Patient Resource